 NEW YORK, Nov. 23, 2020 GLOBE NEWSWIRE -- BeyondSpring Inc. the Company or BeyondSpring NASDAQ: BYSI, a global biopharmaceutical company focused on developing innovative immuno-oncology cancer therapies to transform the lives of patients with unmet medical needs, today announced that management will provide a corporate overview at the 2020 Evercore ISI HealthCONx Conference on December 2, 2020. 